GET3 (ASNA1 / TRC40) — review notes

UniProt: O43681 (GET3_HUMAN). HGNC:752. Synonyms: ARSA (HGNC), ASNA1, TRC40.
348 aa, homodimer, arsA ATPase family (HAMAP MF_03112). EC=3.6.4.-.

Core function: cytosolic ATPase that TARGETS tail-anchored (TA) proteins to the ER

GET3/TRC40/ASNA1 is the central cytosolic ATPase of the GET/TRC pathway. It selectively
recognizes the C-terminal transmembrane domain (TMD) of TA proteins in the cytosol, captures
them (handed off from SGTA via the GET4/UBL4A/BAG6 "bridging"/pre-targeting complex), and
delivers them to the ER-resident WRB/CAML (GET1/GET2) receptor-insertase, where ATP hydrolysis
drives TA release and insertion. GET3 is the targeting factor / chaperone, NOT the insertase
(insertase = WRB/CAML = GET1/GET2).

• [file:human/GET3/GET3-uniprot.txt "ATPase required for the post-translational delivery of tail-anchored (TA) proteins to the endoplasmic reticulum"]
• [file:human/GET3/GET3-uniprot.txt "Recognizes and selectively binds the transmembrane domain of TA proteins in the cytosol."]
• [file:human/GET3/GET3-uniprot.txt "This complex then targets to the endoplasmic reticulum by membrane-bound receptors GET1/WRB and CAMLG/GET2, where the tail-anchored protein is released for insertion."]
• PMID:17382883
• PMID:17382883
• PMID:17382883 — supports MUTAGEN G46R abolishing ATPase + dominantly inhibiting pathway (UniProt FT).
• PMID:21444755
• PMID:21444755
• PMID:23041287

ATPase / ATP binding (MF)

• PMID:9712828 — IDA ATP hydrolysis. Also gives KM/Vmax for ATP (UniProt biophysicochemical).
• PMID:8884272 — IDA ATPase.
• ATP binding/hydrolysis drives the targeting cycle: [file:human/GET3/GET3-uniprot.txt "ATP binding drives the homodimer towards the closed dimer state, facilitating recognition of newly synthesized TA membrane proteins. ATP hydrolysis is required for insertion."]
• ATPase cycle regulated by upstream/downstream factors: PMID:23610396

Protein carrier / chaperone activity (MF)

GO:0140597 "protein carrier chaperone" (label in DR line; GOA labels it "protein carrier activity").
GET3 is a TMD chaperone that shields the hydrophobic TA-TMD and carries it to the ER.
- PMID:23610396
- PMID:23610396
- PMID:34887561

GET complex / receptor (CC + targeting)

• [file:human/GET3/GET3-uniprot.txt "Component of the Golgi to ER traffic (GET) complex, which is composed of GET1/WRB, CAMLG/GET2 and GET3/TRC40"]
• WRB = receptor: PMID:21444755
• CAML = receptor, with WRB: PMID:23041287
• Cryo-EM of GET insertase complex: PMID:32910895 — note: the INSERTASE is WRB/CAML; GET3 is the chaperone.
• ComplexPortal CPX-6464 = GET complex; GOA GET complex part_of annotations (IDA/IPI PMID:32910895, IPI PMID:23041287) are correct.

Pre-targeting / bridging complex interactions (IPI partners)

• GET4 (TRC35): [file:human/GET3/GET3-uniprot.txt "Interacts with GET4 (PubMed:34887561)."]; GOA IPI partners include UniProtKB:Q7L5D6 (GET4). PMID:34887561
• CAMLG (P49069): [file:human/GET3/GET3-uniprot.txt "GET3 shows a higher affinity for CAMLG than for GET1"]; IPI partner UniProtKB:P49069 (CAMLG) in PMID:28514442, 33961781, 40205054, 32296183.
• Bag6 complex transfers TA from SGTA to TRC40: PMID:25535373 — basis for GO:0071816 IDA (MUTAGEN K86D reduces pathway).
• IntAct binary-interactome IPI captures (PMID:21516116, 25416956, 28514442, 32296183, 33961781, 40205054) include many TA-protein-like ER/secretory partners (AGR2, GPX7/8, PGRMC1/2, FKBP7, PDIA6, RCN1, TMX1, etc.) consistent with TA-client capture, plus GET4/CAMLG. Bare "protein binding" is uninformative; keep non-core. PMID:21911467 is a Yersinia pestis–human PPI screen (xeno partner yscD Q56975) — incidental, non-core.

Subcellular location

• Cytoplasm/cytosol (site of action): [file:human/GET3/GET3-uniprot.txt "SUBCELLULAR LOCATION: Cytoplasm"]; EXP PMID:17382883, 21444755; TAS PMID:9736449.
• ER: [file:human/GET3/GET3-uniprot.txt "Endoplasmic reticulum"]; EXP PMID:17382883, 21444755, 31461301. GET3 visits the ER membrane to dock on WRB/CAML. ER membrane (GO:0005789) NAS from ComplexPortal is reasonable as the GET complex resides there.
• Nucleus/nucleolus: [file:human/GET3/GET3-uniprot.txt "Nucleus, nucleolus"]; reported in early arsenite-ATPase papers PMID:9736449 and HPA IDA. This is a secondary/legacy localization not tied to the core TA-targeting function — keep as non-core.
• Extracellular exosome (HDA, PMID:19056867, urinary exosome proteomics): high-throughput proteomic catalog hit; non-core.

Legacy / secondary role: arsenite-stimulated ATPase (arsA homolog)

ASNA1 was originally cloned as the human homolog of bacterial arsA (arsenite transporter ATPase
component). The arsenite stimulation is modest and antimonite does NOT stimulate. This is a
legacy biochemical observation reflecting the ancestral arsA ATPase fold; the gene's bona fide
cellular role is TA-protein targeting. Treat arsenite/antimonite transport framing as
secondary/legacy.
- PMID:8884272
- PMID:9712828
- No arsenite/antimonite transport GO annotation actually appears in the current GOA (only ATP hydrolysis IDA from these papers) — so there is nothing to MARK_AS_OVER_ANNOTATED here; the IDA ATP-hydrolysis annotations are accepted as the genuine MF.

Disease

• CMD2H (dilated cardiomyopathy 2H), autosomal recessive, rapidly progressive infantile.
  PMID:31461301
  Val163Ala mutant: folded protein captures TA but is "inefficient in facilitating TA protein
  insertion into the ER membrane" — directly supports GO:0071816 IMP. asna1-null zebrafish
  cardiac failure rescued by WT but not mutant human ASNA1 mRNA.

Annotation decisions summary

• ATP hydrolysis (IBA, IEA, IDA x2): ACCEPT (core MF). ATP binding (IEA): KEEP_AS_NON_CORE (structural, subsidiary to ATPase).
• GO:0071816 TA insertion into ER (IBA/IEA/IMP x2/IDA): ACCEPT as core BP for the experimental/IBA ones; the BP label says "insertion" but is the standard GO term for the GET-pathway role of the targeting factor — accept.
• GO:0045048 protein insertion into ER membrane (IEA InterPro2GO; NAS ComplexPortal): KEEP_AS_NON_CORE / parent-of-71816, redundant general term.
• GO:0140597 protein carrier activity/chaperone (IDA PMID:23610396): ACCEPT (core MF — TMD chaperone/carrier).
• GET complex part_of (IEA/IPI/IDA): ACCEPT.
• protein binding (IPI, 7 refs): KEEP_AS_NON_CORE (bare term; informative partners captured in notes/complex annotations).
• cytoplasm (IEA/EXP/TAS): ACCEPT. ER (IEA/EXP): ACCEPT. ER membrane (NAS): ACCEPT (GET complex resides there).
• nucleolus (IEA/IDA/TAS), nucleoplasm (IDA): KEEP_AS_NON_CORE (legacy/HPA localization, not core function).
• extracellular exosome (HDA): KEEP_AS_NON_CORE (proteomic catalog).

Falcon deep-research findings (incorporated 2026-06)

• GET3/TRC40 chaperone-captures the TA substrate and delivers it to the Get1/Get2 (WRB/CAML) insertase, which inserts it via a membrane-embedded hydrophilic groove — confirms GET3 is the cytosolic carrier/chaperone, not the insertase. PMID:37963916. Added to supported_by for GO:0140597 protein carrier activity.
• Receptor-driven conformational opening of GET3: the gating interaction between Get2 helix α3' and Get3 drives conformational changes in both Get3 and the Get1/Get2 heterotetramer, promoting Get3 opening and nucleotide release for substrate transfer. PMID:37963916. Mechanistic detail on the GET3 ATP/handoff cycle.
• GET3 gates the insertase channel: in reconstituted membranes, Get3 (TRC40) binding seals the dynamically opening Get1/2 channel, and channel activity is required to release TA proteins from Get3 for insertion. PMID:36640319. Defines the GET3-to-insertase handoff step.
• Pathway review (Farkas & Bohnsack 2021): GET3/TRC40 is the central cytosolic homodimeric ATPase that shields the TA TMD and delivers it to the ER WRB/CAML receptor-insertase; corroborates existing core-function calls. PMID:34264263 (added as HIGH-relevance reference).
• Emerging (NOT added as structured reference — bioRxiv preprint, unverifiable on PubMed): Dempsey et al. 2024 [DOI:10.1101/2024.07.10.602939] propose a redox-regulated switch converting TRC40 from an ATP-dependent TA-targeting ATPase (reduced dimer) into an oligomeric anti-aggregation stress chaperone (oxidized/thiol-blocked tetramers+) under ATP-depleting oxidative stress, reversible with reducing conditions and Mg-ATP. Intriguing dual-mode hypothesis but preprint-only; treat as a candidate question/experiment, not an annotation.